Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsAccurate and Timely Diagnosis of Endometriosis
Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors
Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity
From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes
Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities
"It really pays to be very, very, very skeptical," says one expert
Experts call for better guidance on levothyroxine initiation, deprescribing
1.
Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco
2.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
3.
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia
4.
Health researchers discuss Medicaid cancer screening trends, best practices
5.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
3.
The benefits of using magnesium sulfate during pregnancy
4.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
5.
Tazemetostat: A Promising New Treatment for Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part IV
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation